Skip Navigation LinksHome > Collections > Sleep Disorders

Sleep Disorders

Created:   6/7/2013
Contains:  13 items

NEWS FROM THE AAN ANNUAL MEETING: Suvorexant for Insomnia: A Novel Drug, But at What Dose?

Free Access
PDF
+ Favorites
Request Permissions

VIDEOS ON DEMAND: How can new data on narcolepsy as an autoimmune disorder affect treatment?

Free Access
PDF
+ Favorites
Request Permissions

NEWS FROM THE INTERNATIONAL STROKE CONFERENCE: Sleep Apnea Linked to Brainstem Infarcts

Free Access
PDF
+ Favorites
Request Permissions

For RLS, New Clues on Why Symptoms Worsen Over Time

Free Access
PDF
+ Favorites
Request Permissions

New Evidence for Narcolepsy as an Autoimmune Disorder

Free Access
PDF
+ Favorites
Request Permissions

New Drug for Narcolepsy — with a Novel Mechanism — Found Safe and Effective in European Trial

Free Access
PDF
+ Favorites
Request Permissions

Sleep Found to Clear Toxic Amyloid Beta: Suggests Potential Role for Slowing Alzheimer's Disease

Free Access
PDF
+ Favorites
Request Permissions

TUNE IN: REM SLEEP BEHAVIOR DISORDER: what are the pathologic substrates with a coesxisting neurologic disorder?

Free Access
PDF
+ Favorites
Request Permissions

NEWS FROM THE AAN ANNUAL MEETING: REM Sleep Behavior Disorder + Dementia = Synucleinopathy, Virtually Every Time

Free Access
PDF
+ Favorites
Request Permissions

NEWS FROM THE AAN ANNUAL MEETING: Obstructive Sleep Apnea Associated with Dementia Risk

Free Access
PDF
+ Favorites
Request Permissions

NEWS FROM THE SOCIETY FOR NEUROSCIENCE ANNUAL MEETING: Optogenetics Used to Address Sleep Disorder

Free Access
PDF
+ Favorites
Request Permissions

What Are the Pathologic Substrates of RBD with a Coexisting Neurologic Disorder? Drs. Ringel and Holloway Respond

Neurology Today July 4, 2013, Volume 13, Issue 13;

At this year’s AAN annual meeting, investigators reported that among the neurodegenerative disorders associated with REM sleep behavior disorder (RBD), 94 percent were synucleinopathies, indicating, experts say, that REM sleep behavior disorder is a highly significant prognostic indicator of future neurodegenerative disease. The findings “argue that part of the selective vulnerability involved with Lewy body disease and with MSA likely involves REM sleep circuitry,” study leader Bradley Boeve, MD, chair of behavioral neurology at the Mayo Clinic in Rochester, MN, told attendees of the plenary at the AAN annual meeting. In a video interview, Neurology Today

Editor-in-chief Steven P. Ringel, MD, and Associate Editor Robert G. Holloway, MD, discuss the implications of the study and what to tell patients and their families once REM sleep behavior disorder is diagnosed.

Play Video
+ Favorites

Obstructive Sleep Apnea and Dementia Risk

Neurology Today

From the AAN annual meeting: What is the relationship between obstructive sleep apnea and risk for dementia? David Gill, MD, a cognitive behavioral neurologist at Unit Rehabilitation & Neurology in Rochester, NY, who chose this paper as “noteworthy” from the dementia papers at the AAN annual meeting, offers an analysis of the new data here and what it means for clinicians.

Play Video
+ Favorites
Collection Alerts

Stay up-to-date! Be notified every time a new item is added. Receive an Email or subscribe to an RSS feed.